Interference of 3-O-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice.
Fujitake
J
J
Department of Neurology, Utano National Hospital, Kyoto, Japan.
Kuno
S
S
Mizuta
E
E
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D003342:Corpus Striatum / Q000737:chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D007275:Injections, Intravenous; D007980:Levodopa / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011954:Receptors, Dopamine / Q000187:drug effects; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology
D011954:Receptors, Dopamine; D014443:Tyrosine; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; C008404:3-methoxytyrosine; D004298:Dopamine